Los fabricantes de Wegovy y Zepbound reducen los precios para los que no tienen seguro

Hombre administrándose a sí mismo la inyección de semaglutida, Ozempic, Wegovy

Puntos clave

  • Novo Nordisk redujo el precio de Wegovy a 499 dólares al mes, una disminución del 23%

  • Eli Lilly bajó la dosis inicial de Zepbound a 349 dólares al mes

  • Los precios más bajos están disponibles para pacientes sin seguro y aquellos cuyo seguro no cubre los medicamentos

Originally published on spanish.healthday.com, part of the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.